Choice and switch of biologic drugs in juvenile idiopathic arthritis

Choice and switch of biologic drugs in juvenile idiopathic arthritis

Background. In this study, we aimed to evaluate choices and changes of biologic drugs in juvenile idiopathic arthritis (JIA) patients according to disease subtypes. Methods. We retrospectively analyzed JIA patients who received biologic treatment between January 2004 and July 2022....

Full description

Saved in:
Bibliographic Details
Main Authors: Seher Şener, Özge Başaran, Ezgi Deniz Batu, Müşerref Kasap Cüceoğlu, Zeynep Balık, Emil Aliyev, Yağmur Bayındır, Yelda Bilginer, Seza Özen
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2023-12-01
Series:The Turkish Journal of Pediatrics
Subjects:
adalimumab
anakinra
etanercept
juvenile idiopathic arthritis
Online Access:https://turkjpediatr.org/article/view/109
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items